4.5 Article

Interlaboratory reproducibility of a test method following 4-field test methodology to evaluate the susceptibility of Clostridium difficile spores

期刊

JOURNAL OF HOSPITAL INFECTION
卷 103, 期 1, 页码 78-84

出版社

W B SAUNDERS CO LTD
DOI: 10.1016/j.jhin.2019.04.011

关键词

Clostridium difficile; Sporicidal activity; Reproducibility; Peracetic acid; Glutaraldehyde

资金

  1. Association for Applied Hygiene (VAH), Bonn, Germany

向作者/读者索取更多资源

Background: Sporicidal surface disinfection is recommended to control transmission of Clostridium difficile in healthcare facilities. EN 17126 provides a method to determine the sporicidal activity in suspension and has been approved as a European standard. In addition, a sporicidal surface test has been proposed. Aim: To determine the interlaboratory reproducibility of a test method for evaluating the susceptibility of a C. difficile spore preparation to a biocidal formulation following the 4-field test (EN 16615 methodology). Methods: Nine laboratories participated. C. difficile NCTC 13366 spores were used. Glutaraldehyde (1% and 6%; 15 min) and peracetic acid (PAA; 0.01% and 0.04%; 15 min) were used to determine the spores' susceptibility in suspension in triplicate. Findings: One-percent glutaraldehyde revealed a mean decimal log(10) reduction of 1.03 with variable results in the nine laboratories (0.37-1.49) and a reproducibility of 0.38. The effect of 6% glutaraldehyde was stronger (mean: 2.05; range: 0.96-4.29; reproducibility: 0.86). PAA revealed similar results. An exemplary biocidal formulation based on 5% PAA was used at 0.5% (non-effective concentration) and 4% (effective concentration) to determine the sporicidal efficacy (4-field test) under clean conditions in triplicate with a contact time of 15 min. When used at 0.5% it demonstrated an overall log(10) reduction of 2.68 (range: 2.35-3.57) and at 4% of 4.61 (range: 3.82-5.71). The residual contamination on the three primarily uncontaminated test fields was <50 cfu/25 cm(2) in one out of nine laboratories (0.5%) and in seven out of nine laboratories (4%). Conclusion: The interlaboratory reproducibility seems to be robust. (C) 2019 The Authors. Published by Elsevier Ltd on behalf of The Healthcare Infection Society.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据